n-3 polyunsaturated fatty acids ameliorate obesity with cognitive impairment by promoting adipose browning and remodeling of brain lipid metabolism.
Key claim: Dietary omega-3 fatty acids ameliorate obesity and cognitive impairment in an Alzheimer’s mouse model by promoting adipose tissue browning and reprogramming brain lipid metabolism.
Abstract
In the context of population aging, the global prevalence of obesity and mild cognitive impairment (MCI) continues to rise, underscoring the need for effective interventions. While n-3 polyunsaturated fatty acids (n-3 PUFAs) benefit weight reduction and cognition, the underlying mechanism remains unclear. This study investigated this mechanism using human data and animal models. Cross-sectional analysis of UK Biobank data showed that plasma n-3 PUFA levels were significantly lower in patients with MCI than in healthy controls, indicating an association between lower n-3 PUFA levels and MCI. In a mouse model of obesity with underlying Alzheimer’s disease (AD)-like pathology (high-fat diet-fed 5xFAD mice, a transgenic model of familial AD), dietary fish oil intervention reduced white adipocyte size, upregulated beige fat markers (UCP1 and Prdm16), and improved cognitive performance alongside increased synaptic protein PSD95. Furthermore, n-3 PUFAs decreased plasma pro-inflammatory factors (GROα and Eotaxin) and remodeled the brain lipid profile of obese mice with cognitive impairment. Dietary fish oil intervention significantly increased the brain PUFA content, along with marked elevations in the relative levels of sphingomyelin, diglyceride, triglyceride, fatty acids, phosphatidylcholine, phosphatidic acid, phosphatidylserine, and phosphatidylethanolamine, whereas ceramide levels were significantly reduced. These findings suggest that n-3 PUFAs may ameliorate obesity and cognitive impairment in the context of underlying AD pathology through two parallel mechanisms linked to lipid metabolism: promoting adipose tissue browning and directly reprogramming brain lipid metabolism.
Why this matters
[animal-model] This finding connects dietary fat composition to adipose thermogenic remodeling and brain lipid metabolism in an Alzheimer’s mouse model, extending the area’s adiposity–cognition research beyond body weight alone. [animal-model] The reported metabolic, molecular and cognitive-performance improvements are preclinical endpoints, not evidence of reduced human dementia incidence or lifespan extension; [human-observational] the accompanying human cross-sectional data cannot establish intervention effects or validate the proposed causal pathways.